Nahdi Medical Company
4164
Rang in Aktien
#4842
Nahdi Medical Company stands as a prominent pharmaceutical retail chain with... Nahdi Medical Company stands as a prominent pharmaceutical retail chain with operations spanning both the Kingdom of Saudi Arabia and the United Arab Emirates. Its extensive product portfolio encompasses a diverse range of pharmaceutical goods, health and wellness items, maternal and infant care essentials, beauty products, and various fast-moving consumer goods. Beyond retail, Nahdi provides a comprehensive suite of omni-health services, including polyclinics, rapid-care clinics, telemedicine platforms, laboratory facilities, and home healthcare programs. The company is also actively involved in the wholesale and retail distribution of cosmetics, medicines, specialized dietary products, healthy food options, and medical equipment. With approximately 1,151 pharmacies under its management, Nahdi Medical Company was established in 1986 and maintains its headquarters in Jeddah, Saudi Arabia. It operates as a subsidiary under the umbrella of both Alnahdi Holding Company Limited and Saudi Economic and Development Company Limited.
Aktienkurs
$23.53
Zuletzt synchronisiert: 2026-10-19
Marktkapitalisierung
$3.06B
Veränderung (1 Tag)
-0.95%
Veränderung (1 Jahr)
-26.76%
Land
SA
Handel Nahdi Medical Company (4164)
Kategorie
Healthcare
Gewinn für Nahdi Medical Company (4164)
Gewinn im Jun 2026 TTM: $217.74M
Laut den aktuellen Finanzberichten von Nahdi Medical Company betragen die aktuellen Gewinne des Unternehmens $217.74M. Im Jahr 2023 erzielte das Unternehmen einen Gewinn von $251.81M, eine Steigerung gegenüber dem Gewinn im Jahr 2022, der $249.53M betrug. Die auf dieser Seite angezeigten Gewinne sind die Gewinne vor Zinsen und Steuern, auch bekannt als EBIT.
Gewinnverlauf von Nahdi Medical Company von 2017 bis 2026
Gewinn am Ende jedes Jahres
| Jahr | Gewinn | ändert |
|---|---|---|
| 2026 (TTM) | $217.74M | -1.98% |
| 2024 | $222.14M | -11.78% |
| 2023 | $251.81M | 0.91% |
| 2022 | $249.53M | 9.27% |
| 2021 | $228.35M | -4.23% |
| 2020 | $238.42M | 16.36% |
| 2019 | $204.91M | 20.34% |
| 2018 | $170.27M | -15.09% |
| 2017 | $200.53M | 0.00% |
Gewinn ähnlicher Unternehmen oder Konkurrenten
| Unternehmen | Gewinn | Gewinnunterschied | Land |
|---|---|---|---|
| $1.35B | 519.94% |
US
|
|
| - | - |
SE
|
|
| - | - |
FR
|
|
| - | - |
IT
|
|
| $1.21B | 453.44% |
HK
|
